Semaglutide, which acts in the brain to reduce food intake, has fast become one of the most effective pharmaceutical weapons in the global battle against obesity. GLP1-based obesity medicines are the subject of intense public debate as governments seek to harness their public health potential. But semaglutide’s positive impact on weight loss is sometimes offset […]
Semaglutide without the sickness?
